ALLMedicine™ Diabetic Neuropathy Center

Mar 18th, 2023 - Diabetes is a chronic disease and has huge pressure on patients and the medical system, especially for patients with diabetic complications, for example, diabetic nephropathy. Diabetic nephropathy is a diabetic complication associated with damage ...

Mar 18th, 2023 - Diabetic polyneuropathy (DPN) renders progressive sensory neurodegeneration linked to hyperglycemia and its associated metabolopathy. Here we hypothesized that there may be additive impacts of direct insulin signaling, independent of glycemia and ...

Mar 17th, 2023 - Diabetic peripheral neuropathy (DPN) is one of the risk factors for foot-related complications among people with type 2 diabetes mellitus (T2DM). Hence, we aimed to validate the Michigan Neuropathy Screening Instrument (MNSI) tool against biothesi...

Mar 12th, 2023 - The aim of this study was to assess patient perspectives and experiences of the impact of neuropathic pain, painful diabetic neuropathy (pDPN) diagnosis and treatment, and the patient-healthcare professional (HCP) relationship. We conducted a quan...

Mar 10th, 2023 - The purpose of this protocol is to examine the long-term impact of treatment with the angiotensin receptor blocker losartan on progression of diabetic kidney disease in American Indians with type 2 diabetes. Data from this protocol will also be us...

Aug 18th, 2021 - Diabetic Neuropathy.|2021|Ziegler D,Keller J,Maier C,Pannek J,|diagnosis,epidemiology,etiology,therapy,standards,methods,organization & administration,standards,epidemiology,methods,standards,methods,standards,

Jun 23rd, 2011 - The Cardiovascular Autonomic Neuropathy (CAN) Subcommittee of the Toronto Consensus Panel on Diabetic Neuropathy worked to update CAN guidelines, with regard to epidemiology, clinical impact, diagnosis, usefulness of CAN testing, and management. C...

Apr 13th, 2011 - To develop a scientifically sound and clinically relevant evidence-based guideline for the treatment of painful diabetic neuropathy (PDN). We performed a systematic review of the literature from 1960 to August 2008 and classified the studies accor...

Mar 10th, 2023 - The purpose of this protocol is to examine the long-term impact of treatment with the angiotensin receptor blocker losartan on progression of diabetic kidney disease in American Indians with type 2 diabetes. Data from this protocol will also be us...

Mar 9th, 2023 - The TopCSPN trial is a double blinded randomized placebo controlled study of oral topiramate as a potential disease modifying therapy for cryptogenic sensory peripheral neuropathy (CSPN). Patients with CSPN who also have metabolic syndrome (define...

Mar 9th, 2023 - Diabetic neuropathy is the most common complication associated with diabetes mellitus, affecting approximately 50-70% of patients with diabetes. The prevalence of pain and of paraesthesia were 20% and 33% 10 years after diagnosis of diabetes melli...

Mar 8th, 2023 - In the phase III VMDN-003 study, subjects received 2 treatments of either Engensis (VM202) or placebo administered as intramuscular (IM) injections into bilateral calves on Days 0 and 14, and Days 90 and 104. Primary efficacy was evaluated 90 days...

Mar 6th, 2023 - Historically, participation in clinical studies is highly skewed towards particular demographic groups of people. This study will invite several participants to gather a wide range of information on clinical trial experiences for diabetic neuropat...

Jan 31st, 2023 - The 24-month ALERTT1 trial found that switching to a real-time continuous glucose monitor from an intermittently scanned one significantly improved glycemic control and hypoglycemia worry score for people with type 1 diabetes. (The Lancet Diabetes...

Jan 31st, 2023 - People with diabetes who adhere to a healthy diet, exercise regularly, and follow other healthy lifestyle practices have a significantly lower risk of microvascular complications from the disease, such as diabetic neuropathy, retinopathy, and neph.

Nov 1st, 2022 - The opioid crisis presents a need to consider alternative options for treating chronic pain. There is significant overlap in neuroanatomical circuits that process pain, emotions, and motivation.

Oct 19th, 2022 - This transcript has been edited for clarity. Good afternoon. I'm going to talk to you about the SENZA-PDN trial. This is a randomized controlled trial conducted in patients with peripheral diabetic neuropathy. It's a really important indication be...

Sep 19th, 2022 - Professor Pardeep Jhund, from the University of Glasgow, United Kingdom, discusses highlights in diabetes and heart disease presented at the European Society of Cardiology Congress 2022. He begins with a Danish study of the causes of excess mortal.